|
1
|
Heron M and Anderson RN: Changes in the
leading cause of death: Recent patterns in heart disease and cancer
mortality. NCHS Data Brief. 254:1–8. 2016.PubMed/NCBI
|
|
2
|
Steeg PS: Targeting metastasis. Nat Rev
Cancer. 16:201–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maiuthed A, Chantarawong W and
Chanvorachote P: Lung cancer stem cells and cancer stem
cell-targeting natural compounds. Anticancer Res. 38:3797–3809.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pardal R, Clarke MF and Morrison SJ:
Applying the principles of stem-cell biology to cancer. Nat Rev
Cancer. 3:895–902. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koren E and Fuchs Y: The bad seed: Cancer
stem cells in tumor development and resistance. Drug Resist Updat.
28:1–12. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Adorno-Cruz V, Kibria G, Liu X, Doherty M,
Junk DJ, Guan D, Hubert C, Venere M, Mulkearns-Hubert E, Sinyuk M,
et al: Cancer stem cells: Targeting the roots of cancer, seeds of
metastasis, and sources of therapy resistance. Cancer Res.
75:924–929. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nassar D and Blanpain C: Cancer stem
cells: Basic concepts and therapeutic implications. Annu Rev
Pathol. 11:47–76. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Andrews PW, Damjanov I, Berends J, Kumpf
S, Zappavigna V, Mavilio F and Sampath K: Inhibition of
proliferation and induction of differentiation of pluripotent human
embryonal carcinoma cells by osteogenic protein-1 (or bone
morphogenetic protein-7). Lab Invest. 71:243–251. 1994.PubMed/NCBI
|
|
9
|
Donovan PJ and Gearhart J: The end of the
beginning for pluripotent stem cells. Nature. 414:92–97. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rodda DJ, Chew JL, Lim LH, Loh YH, Wang B,
Ng HH and Robson P: Transcriptional regulation of nanog by Oct4 and
Sox2. J Biol Chem. 280:24731–24737. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sp N, Kang DY, Kim DH, Park JH, Lee HG,
Kim HJ, Darvin P, Park YM and Yang YM: Nobiletin inhibits
CD36-dependent tumor angiogenesis, migration, invasion, and sphere
formation through the CD36/Stat3/NF-kB signaling axis. Nutrients.
10:7722018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pitrone M, Pizzolanti G, Tomasello L,
Coppola A, Morini L, Pantuso G, Ficarella R, Guarnotta V, Perrini
S, Giorgino F and Giordano C: NANOG plays a hierarchical role in
the transcription network regulating the pluripotency and
plasticity of adipose tissue-derived stem cells. Int J Mol Sci.
18:11072017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang YS, Eades G, Yao Y, Li QL and Zhou
Q: Estrogen receptor alpha signaling regulates breast
tumor-initiating cells by down-regulating miR-140 which targets the
transcription factor SOX2. J Biol Chem. 287:41514–41522. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Eini R, Stoop H, Gillis AJ, Biermann K,
Dorssers LC and Looijenga LH: Role of SOX2 in the etiology of
embryonal carcinoma, based on analysis of the NCCIT and NT2 cell
lines. PLoS One. 9:e835852014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jeter CR, Yang T, Wang JC, Chao HP and
Tang DG: Concise review: NANOG in cancer stem cells and tumor
development: An update and outstanding questions. Stem Cells.
33:2381–2390. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin T, Ding YQ and Li JM: Overexpression
of Nanog protein is associated with poor prognosis in gastric
adenocarcinoma. Med Oncol. 29:878–885. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang J, Zhao XY, Tang M, Li L, Lei Y,
Cheng P, Guo W, Zheng Y, Wang W, Luo N, et al: The role of ROS and
subsequent DNA-damage response in PUMA-induced apoptosis of ovarian
cancer cells. Oncotarget. 8:23492–23506. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Srinivas US, Tan BWQ, Vellayappan BA and
Jeyasekharan AD: ROS and the DNA damage response in cancer. Redox
Biol. 25:1010842019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ye Z, Shi Y, Lees-Miller SP and Tainer JA:
Function and molecular mechanism of the DNA damage response in
immunity and cancer immunotherapy. Front Immunol. 12:7978802021.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maréchal A and Zou L: DNA damage sensing
by the ATM and ATR kinases. Cold Spring Harb Perspect Biol.
5:a0127162013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou BB and Elledge SJ: The DNA damage
response: Putting checkpoints in perspective. Nature. 408:433–439.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Banin S, Moyal L, Shieh S, Taya Y,
Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y
and Ziv Y: Enhanced phosphorylation of p53 by ATM in response to
DNA damage. Science. 281:1674–1677. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Visconti R, Della Monica R and Grieco D:
Cell cycle checkpoint in cancer: A therapeutically targetable
double-edged sword. J Exp Clin Cancer Res. 35:1532016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Malumbres M: Cyclin-dependent kinases.
Genome Biol. 15:1222014. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Deng C, Zhang P, Harper JW, Elledge SJ and
Leder P: Mice lacking P21Cip1/WAF1 undergo normal development, but
are defective in G1 checkpoint CONTROL. Cell. 82:675–684. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Abbas T and Dutta A: p21 in cancer:
Intricate networks and multiple activities. Nat Rev Cancer.
9:400–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hong B, van den Heuvel AP, Prabhu VV,
Zhang S and El-Deiry WS: Targeting tumor suppressor p53 for cancer
therapy: Strategies, challenges and opportunities. Curr Drug
Targets. 15:80–89. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stöcker W, Grams F, Baumann U, Reinemer P,
Gomis-Rüth FX, McKay DB and Bode W: The metzincins-topological and
sequential relations between the astacins, adamalysins,
serralysins, and matrixins (collagenases) define a superfamily of
zinc-peptidases. Protein Sci. 4:823–840. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lohi J, Wilson CL, Roby JD and Parks WC:
Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed
in testis and keratinocytes and in response to injury. J Biol Chem.
276:10134–10144. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hadler-Olsen E, Winberg JO and
Uhlin-Hansen L: Matrix metalloproteinases in cancer: Their value as
diagnostic and prognostic markers and therapeutic targets. Tumour
Biol. 34:2041–2051. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu JS, Sheng SR, Liang XH and Tang YL: The
role of tumor microenvironment in collective tumor cell invasion.
Future Oncol. 13:991–1002. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Russo S, Cinausero M, Gerratana L, Bozza
C, Iacono D, Driol P, Deroma L, Sottile R, Fasola G and Puglisi F:
Factors affecting patient's perception of anticancer treatments
side-effects: An observational study. Expert Opin Drug Saf.
13:139–150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wamukaya JW and Philis PB: Outcome of
supportive management in the prevention of chemotherapy induced
nausea and vomiting in a resource limited set up-nurse experience.
Asia-Pac J Clin Oncol. 10:194–196. 2014.
|
|
36
|
Sp N, Kang DY, Joung YH, Park JH, Kim WS,
Lee HK, Song KD, Park YM and Yang YM: Nobiletin inhibits
angiogenesis by regulating Src/FAK/STAT3-mediated signaling through
PXN in ER+ breast cancer cells. Int J Mol Sci. 18:9352017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sp N, Kang DY, Lee JM, Bae SW and Jang KJ:
Potential antitumor effects of 6-gingerol in p53-dependent
mitochondrial apoptosis and inhibition of tumor sphere formation in
breast cancer cells. Int J Mol Sci. 22:46602021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lin SR, Fu YS, Tsai MJ, Cheng H and Weng
CF: Natural compounds from herbs that can potentially execute as
autophagy inducers for cancer therapy. Int J Mol Sci. 18:14122017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rugamba A, Kang DY, Sp N, Jo ES, Lee JM,
Bae SW and Jang KJ: Silibinin regulates tumor progression and
tumorsphere formation by suppressing PD-L1 expression in non-small
cell lung cancer (NSCLC) cells. Cells. 10:16322021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sp N, Kang DY, Jo ES, Lee JM, Bae SW and
Jang KJ: Pivotal role of iron homeostasis in the induction of
mitochondrial apoptosis by 6-gingerol through pten regulated PD-L1
expression in embryonic cancer cells. Front Oncol. 11:7817202021.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ouyang L, Luo Y, Tian M, Zhang SY, Lu R,
Wang JH, Kasimu R and Li X: Plant natural products: From
traditional compounds to new emerging drugs in cancer therapy. Cell
Prolif. 47:506–515. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Huang M, Lu JJ and Ding J: Natural
products in cancer therapy: Past, present and future. Nat Prod
Bioprospect. 11:5–13. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ali Abdalla YO, Subramaniam B, Nyamathulla
S, Shamsuddin N, Arshad NM, Mun KS, Awang K and Nagoor NH: Natural
products for cancer therapy: A review of their mechanism of actions
and toxicity in the past decade. J Trop Med. 2022:57943502022.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Talib WH, Alsalahat I, Daoud S, Abutayeh
RF and Mahmod AI: Plant-derived natural products in cancer
research: Extraction, mechanism of action, and drug formulation.
Molecules. 25:53192020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shahrzad S, Aoyagi K, Winter A, Koyama A
and Bitsch I: Pharmacokinetics of gallic acid and its relative
bioavailability from tea in healthy humans. J Nutr. 131:1207–1210.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Nabavi SF, Habtemariam S, Di Lorenzo A,
Sureda A, Khanjani S, Nabavi SM and Daglia M: Post-stroke
depression modulation and in vivo antioxidant activity of gallic
acid and its synthetic derivatives in a murine model system.
Nutrients. 8:2482016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Abdelwahed A, Bouhlel I, Skandrani I,
Valenti K, Kadri M, Guiraud P, Steiman R, Mariotte AM, Ghedira K,
Laporte F, et al: Study of antimutagenic and antioxidant activities
of gallic acid and 1,2,3,4,6-pentagalloylglucose from Pistacia
Lentiscus. Confirmation by microarray expression profiling. Chem
Biol Interact. 165:1–13. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Velderrain-Rodríguez GR, Torres-Moreno H,
Villegas-Ochoa MA, Ayala-Zavala JF, Robles-Zepeda RE, Wall-Medrano
A and González-Aguilar GA: Gallic acid content and an antioxidant
mechanism are responsible for the antiproliferative activity of
‘Ataulfo’ mango peel on LS180 cells. Molecules. 23:6952018.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kim SW, Han YW, Lee ST, Jeong HJ, Kim SH,
Kim IH, Lee SO, Kim DG, Kim SH, Kim SZ and Park WH: A superoxide
anion generator, pyrogallol, inhibits the growth of HeLa cells via
cell cycle arrest and apoptosis. Mol Carcinog. 47:114–125. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sorrentino E, Succi M, Tipaldi L, Pannella
G, Maiuro L, Sturchio M, Coppola R and Tremonte P: Antimicrobial
activity of gallic acid against food-related pseudomonas strains
and its use as biocontrol tool to improve the shelf life of fresh
black truffles. Int J Food Microbiol. 266:183–189. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Couto AG, Kassuya CAL, Calixto JB and
Petrovick PR: Anti-inflammatory, antiallodynic effects and
quantitative analysis of gallic acid in spray dried powders from
Phyllanthus Niruri leaves, stems, roots and whole plant. Rev Bras
Farmacogn. 23:124–131. 2013. View Article : Google Scholar
|
|
52
|
Lee JH, Oh M, Seok JH, Kim S, Lee DB, Bae
G, Bae HI, Bae SY, Hong YM, Kwon SO, et al: Antiviral effects of
black raspberry (Rubus coreanus) seed and its gallic acid against
influenza virus infection. Viruses. 8:1572016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Rasooly R, Choi HY, Do P, Morroni G,
Brescini L, Cirioni O, Giacometti A and Apostolidis E:
whISOBAXTM inhibits bacterial pathogenesis and enhances
the effect of antibiotics. Antibiotics (Basel). 9:2642020.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Schimites PI, Segat HJ, Teixeira LG,
Martins LR, Mangini LT, Baccin PS, Rosa HZ, Milanesi LH, Burger ME
and Soares AV: Gallic acid prevents ketamine-induced oxidative
damages in brain regions and liver of rats. Neurosci Lett.
714:1345602020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang TX, Ma LJ, Wu PF, Li W, Li T, Gu R,
Dan X, Li Z, Fan X and Xiao Z: Gallic acid has anticancer activity
and enhances the anticancer effects of cisplatin in non-small cell
lung cancer A549 cells via the JAK/STAT3 signaling pathway. Oncol
Rep. 41:1779–1788. 2019.PubMed/NCBI
|
|
56
|
You BR, Moon HJ, Han YH and Park WH:
Gallic acid inhibits the growth of HeLa cervical cancer cells via
apoptosis and/or necrosis. Food Chem Toxicol. 48:1334–1340. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Subramanian AP, Jaganathan SK, Mandal M,
Supriyanto E and Muhamad II: Gallic acid induced apoptotic events
in HCT-15 colon cancer cells. World J Gastroenterol. 22:3952–3961.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Tang HM and Cheung PCK: Gallic acid
triggers iron-dependent cell death with apoptotic, ferroptotic, and
necroptotic features. Toxins (Basel). 11:4922019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Phan AN, Hua TN, Kim MK, Vo VT, Choi JW,
Kim HW, Rho JK, Kim KW and Jeong Y: Gallic acid inhibition of
Src-Stat3 signaling overcomes acquired resistance to EGF receptor
tyrosine kinase inhibitors in advanced non-small cell lung cancer.
Oncotarget. 7:54702–54713. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Liao CC, Chen SC, Huang HP and Wang CJ:
Gallic acid inhibits bladder cancer cell proliferation and
migration via regulating fatty acid synthase (FAS). J Food Drug
Anal. 26:620–627. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zeng M, Su Y, Li K, Jin D, Li Q, Li Y and
Zhou B: Gallic acid inhibits bladder cancer T24 cell progression
through mitochondrial dysfunction and PI3K/Akt/NF-ĸB signaling
suppression. Front Pharmacol. 11:12222020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Li Z, Bao S, Wu Q, Wang H, Eyler C,
Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, et al:
Hypoxia-inducible factors regulate tumorigenic capacity of glioma
stem cells. Cancer Cell. 15:501–513. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Dawood S, Austin L and Cristofanilli M:
Cancer stem cells: Implications for cancer therapy. Oncology
(Williston Park). 28:1101–1107. 11102014.PubMed/NCBI
|
|
64
|
Brehmer B, Kauffmann C, Blank C,
Heidenreich A and Bex A: Resection of metastasis and local
recurrences of renal cell carcinoma after presurgical targeted
therapy: Probability of complete local control and outcome. World J
Urol. 34:1061–1066. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ewald B, Sampath D and Plunkett W:
Nucleoside analogs: Molecular mechanisms signaling cell death.
Oncogene. 27:6522–6537. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wilson TR, Johnston PG and Longley DB:
Anti-apoptotic mechanisms of drug resistance in cancer. Curr Cancer
Drug Targets. 9:307–319. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Rochat B: Importance of influx and efflux
systems and xenobiotic metabolizing enzymes in intratumoral
disposition of anticancer agents. Curr Cancer Drug Targets.
9:652–674. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kang DY, Darvin P, Yoo YB, Joung YH, Sp N,
Byun HJ and Yang YM: Methylsulfonylmethane inhibits HER2 expression
through STAT5b in breast cancer cells. Int J Oncol. 48:836–842.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Sp N, Darvin P, Yoo YB, Joung YH, Kang DY,
Kim DN, Hwang TS, Kim SY, Kim WS, Lee HK, et al: The combination of
methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b
pathway and synergistically inhibits tumor growth and metastasis in
ER-positive breast cancer xenografts. BMC Cancer. 15:4742015.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Kang DY, Sp N, Jo ES, Rugamba A, Hong DY,
Lee HG, Yoo JS, Liu Q, Jang KJ and Yang YM: The inhibitory
mechanisms of tumor PD-L1 expression by natural bioactive gallic
acid in non-small-cell lung cancer (NSCLC) cells. Cancers (Basel).
12:7272020. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ko EB, Jang YG, Kim CW, Go RE, Lee HK and
Choi KC: Gallic acid hindered lung cancer progression by inducing
cell cycle arrest and apoptosis in A549 lung cancer cells via
PI3K/Akt pathway. Biomol Ther (Seoul). 30:151–161. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
He Z, Liu X, Wu F, Wu S, Rankin GO,
Martinez I, Rojanasakul Y and Chen YC: Gallic acid induces S and G2
phase arrest and apoptosis in human ovarian cancer cells in vitro.
Appl Sci (Basel). 11:38072021. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Sp N, Kang DY, Jo ES, Lee JM and Jang KJ:
Iron metabolism as a potential mechanism for inducing
TRAIL-mediated extrinsic apoptosis using methylsulfonylmethane in
embryonic cancer stem cells. Cells. 10:28472021. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Weng SW, Hsu SC, Liu HC, Ji BC, Lien JC,
Yu FS, Liu KC, Lai KC, Lin JP and Chung JG: Gallic acid induces DNA
damage and inhibits DNA repair-associated protein expression in
human oral cancer SCC-4 cells. Anticancer Res. 35:2077–2084.
2015.PubMed/NCBI
|
|
76
|
Liu KC, Ho HC, Huang AC, Ji BC, Lin HY,
Chueh FS, Yang JS, Lu CC, Chiang JH, Meng M, et al: Gallic acid
provokes DNA damage and suppresses DNA repair gene expression in
human prostate cancer PC-3 cells. Environ Toxicol. 28:579–587.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Setayesh T, Nersesyan A, Mišík M,
Noorizadeh R, Haslinger E, Javaheri T, Lang E, Grusch M, Huber W,
Haslberger A and Knasmüller S: Gallic acid, a common dietary
phenolic protects against high fat diet induced dna damage. Eur J
Nutr. 58:2315–2326. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Lockhart AC, Braun RD, Yu D, Ross JR,
Dewhirst MW, Humphrey JS, Thompson S, Williams KM, Klitzman B, Yuan
F, et al: Reduction of wound angiogenesis in patients treated with
BMS-275291, a broad spectrum matrix metalloproteinase inhibitor.
Clin Cancer Res. 9:586–593. 2003.PubMed/NCBI
|
